Small nucleolar RNA host gene 22 (SNHG22) promotes the progression of esophageal squamous cell carcinoma by miR-429/SESN3 axis

• Published in: Annals of translational medicine Vol. 8; no. 16; p. 1007
• Main Authors: Li, Zhong-Wen, Zhang, Ting-You, Yue, Guo-Jun, Tian, Xin, Wu, Jin-Zhi, Feng, Guang-Yong, Wang, Yong-Sheng
• Format: Journal Article
• Language: English
• Published: China 01.08.2020
• Subjects: miR-429; esophageal squamous cell carcinoma (ESCC); SESN3; Small nucleolar RNA host gene 22 (SNHG22)
• ISSN: 2305-5839; 2305-5839
• DOI: 10.21037/atm-20-5332

It has been observed that lncRNAs have been taking part in many cancer progressions, including non-small cell lung cancer and gastric cancer. Meanwhile, lncRNA small nucleolar RNA host gene 22 (SNHG22) has been studied, taking part in the progression of ovarian epithelial carcinoma. However, we know little about the function of SNHG22 in esophageal squamous cell carcinoma (ESCC). In this study, we will explore the inner mechanism of SNHG22 in ESCC. Quantitative real-time PCR (qRT-PCR) assay was implemented in ESCC cells for detecting the expression of lncRNA, SNHG22, and miR-429. Also, functional experiments, including CCK8 and colony formation assay, were implemented to assess the growth of ESCC cells. Meanwhile, flow cytometry analysis was conducted to test the apoptosis of ESCC cells. The immunofluorescence (IF) assay and western blot were conducted to verify the autophagy of ESCC cells. Inhibition of SNHG22 was found that can inhibit the progression and promotes autophagy and apoptosis of ESCC cells. Meanwhile, as subcellular fraction assay and FISH assay found that SNHG22 mainly in the cytoplasm, miR-429 was found can bind to SNHG22 and SESN3 by RIP assay and luciferase reporter assay. SESN3 was found it can play the oncogene in ESCC cells. SNHG22 promotes the progression of ESCC by the miR-429/SESN3 axis.